Advanced Emissions Solutions Announces $10 Million Stock Repurchase Program
Dec 04, 2017 12:20 pm UTC| Business
HIGHLANDS RANCH, Colo., Dec. 04, 2017 -- Advanced Emissions Solutions, Inc. (NASDAQ:ADES) (the “Company" or “ADES”) today announced that its Board of Directors has approved the repurchase of up to $10 million of the...
PHI Group’s Former Subsidiary Signs Contracts for 2,400,000 MT of D2 and HSD Euro-IV with Refinery
Dec 04, 2017 12:15 pm UTC| Business
NEW YORK, Dec. 04, 2017 -- PHI Group, Inc., (www.phiglobal.com) (OTCQB:PHIL), a company focused on mergers and acquisitions and investments in natural resources, energy, agriculture and special situations, announced...
Melco Resorts & Entertainment Continues to Lead Macau with the Most Michelin-Starred Restaurants
Dec 04, 2017 12:04 pm UTC| Business
MACAU, Dec. 04, 2017 -- Melco Resorts Entertainment (NASDAQ:MLCO) (“Melco” or the “Company”) is proud to announce that the Michelin guide, long regarded as the world's foremost authority on culinary merit, today...
Dec 04, 2017 12:01 pm UTC| Business
- Epidiolex® (cannabidiol) NDA Submitted to FDA -- Conference call today at 7:30 a.m. EST - LONDON and CARLSBAD, Calif., Dec. 04, 2017 -- GW Pharmaceuticals plc (Nasdaq:GWPH) (GW, the Company or the Group), a...
Dec 04, 2017 12:01 pm UTC| Business
TORONTO, Dec. 04, 2017 -- NextSource Materials Inc. (TSX:NEXT) (OTCQB:NSRC) (“NextSource” or the “Company”) has received numerous inquiries from stockholders regarding how to vote their respective shares in their...
Akoustis® to Present First Published Single Crystal 5GHz BAW Filter Results at IEDM
Dec 04, 2017 12:01 pm UTC| Business
San Francisco, C.A , Dec. 04, 2017 -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), a manufacturer of patented single-crystal BulkONE® bulk acoustic wave (BAW) high-band RF filters for mobile...
Arix Bioscience leads $30 million financing for Atox Bio
Dec 04, 2017 12:01 pm UTC| Business
Arix Bioscience leads $30 million financing for Atox Bio Funding to advance Reltecimod into a Phase 2 clinical study for acute kidney injury, building upon Atox Bio's on-going Phase 3 clinical development in...
UK Inflation Stabilizes: November CPI at 2.6%, Signaling Economic Recovery
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update